Giuseppe Badalamenti

Author

Also Known As

Antonella Bianco, DI BISCEGLIE M, G Badalamenti, G. BADALAMENTI, G. Badalamenti, Giuseppe Badalamenti, Giuseppe Badalamenti (503251)

309

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

University of Palermo Fondazione IRCCS Istituto Nazionale dei Tumori Università Campus Bio-Medico Istituti di Ricovero e Cura a Carattere Scientifico Candiolo Cancer Institute

About

Giuseppe Badalamenti is an author at University of Palermo specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	2.4K
2	Health Sciences	5	5	141
3	Engineering	1	1	14
4	Biology	1	1	12
5	Cell Biology	1	1	54

Giuseppe Badalamenti

Publications

4.1K

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial George D. Demetri, Peter Reichardt, Yoon‐Koo Kang, The Lancet Gastrointestinal OncologyMedicinePharmacologyPathologyPharmacotherapy	2012	1.4K
Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study Paola Sperone, Annamaria Ferrero, Fulvia Daffara, Endocrine Related Cancer Advanced Acc ProgressingSecond-/third-line ChemotherapyAdrenocortical CarcinomaMedicineMetronomic Therapy	2010	162
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases Daniele Santini, Sandro Barni, Salvatore Intagliata, Scientific Reports	2015	136
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study Daniele Santini, Marco Tampellini, Bruno Vincenzi, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineNatural HistoryColorectal Cancer	2012	129
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer Gaetano Leto, Lorena Incorvaia, Giuseppe Badalamenti, Clinical & Experimental Metastasis UrologyBreast OncologyMedicinePathologyBreast Cancer	2006	115
Natural History of Malignant Bone Disease in Renal Cancer: Final Results of an Italian Bone Metastasis Survey Daniele Santini, Giuseppe Procopio, Camillo Porta, PLoS ONE	2013	90
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial Sabino De Placido, Ciro Gallo, Michelino De Laurentiis, The Lancet Oncology Endocrine OncologyBreast OncologyMedicinePharmacologyEndocrine-sensitive Breast Cancer	2018	86
Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis? Matteo Santoni, Alessandro Conti, Giuseppe Procopio, Journal of Experimental & Clinical Cancer Research	2015	85
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Lorena Incorvaia, Giuseppe Badalamenti, GiovamBattista Rini, PubMed	2007	82
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions Lorena Incorvaia, Daniele Fanale, Giuseppe Badalamenti, OncoImmunology	2020	79

Page 1